Clinical Trial Update: MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects [Phase 3]

View source ↗

Summary

Open-label long-term extension safety study of mepolizumab in asthmatic subjects completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-05-22